The Cigna Group (BSP:C1IC34) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:C1IC34 The Cigna Group BSP:C1IC34
67 GF Score
Price R$379.42
GF Value R$553.60
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Cigna Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

The Cigna Group Valuation Rank Related Terms

BSP:C1IC34
67GF Score
The Cigna Group BSP:C1IC34
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The Cigna Group (BSP:C1IC34) Overvalued in 2026?

Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued. The current stock price of R$379.42 is trading 31.5% below its estimated GF Value™ of R$553.60. GuruFocus considers The Cigna Group to be Significantly Undervalued.

Key valuation signals for BSP:C1IC34:

  • Valuation Rank:
  • GF Value™: R$553.60 vs. price of R$379.42 (31.5% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the BSP:C1IC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
67GF Score

Get the complete analysis for BSP:C1IC34

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$379.42
Price
R$553.60
GF Value